Semaglutide is contraindicated in patients with: Personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Common Adverse Effects According to clinical trial data, gastrointestinal effects are most frequently reported: nausea, vomiting, diarrhea, constipation, and abdominal discomfort
Patients who maintain some form of treatment continuity, whether through medication switches, restarts, or regular contact with dietitians and weight management specialists, appear to fare better than trial conditions would predict
Expect defendants to argue the clock started at first diagnosis, hospitalization, or when you were told the likely cause
Some doctors prescribe it off-label for weight loss, but thats not its official use